Concepedia

Publication | Open Access

The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial

DOIFull Paper Access

47

Citations

27

References

2018

Year

Naimish Patel, Danen Cunoosamy, Malin Fagerås, Ziad Taib, Sara Asimus, Tove Hegelund-Myrbäck, Sofia Lundin, Katerina Pardali, Nisha Kurian, Eva Ersdal,
International Journal of COPD

Abstract

Although p38α is upregulated in the lungs of COPD patients, AZD7624, an isoform-specific inhaled p38 MAPK inhibitor, failed to show any benefit in patients with COPD.

References

YearCitations

Page 1